Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda

Jonathan S. Towner(Centers for Disease Control and Prevention), Tara K. Sealy(Centers for Disease Control and Prevention), Marina L. Khristova(Centers for Disease Control and Prevention), César G. Albariño(Centers for Disease Control and Prevention), Sean Conlan(Columbia University), Serena A. Reeder(Centers for Disease Control and Prevention), Phenix‐Lan Quan(Columbia University), W. Ian Lipkin(Columbia University), R. G. Downing(Centers for Disease Control and Prevention), Jordan W. Tappero(Centers for Disease Control and Prevention), Samuel Okware(Ministry of Health), Julius J. Lutwama(Uganda Virus Research Institute), Barnabas Bakamutumaho(Uganda Virus Research Institute), John Kayiwa(Uganda Virus Research Institute), James A. Comer(Centers for Disease Control and Prevention), Pierre E. Rollin(Centers for Disease Control and Prevention), Thomas G. Ksiazek(Centers for Disease Control and Prevention), Stuart T. Nichol(Centers for Disease Control and Prevention)
PLoS Pathogens
November 20, 2008
Cited by 549Open Access
Full Text

Abstract

Over the past 30 years, Zaire and Sudan ebolaviruses have been responsible for large hemorrhagic fever (HF) outbreaks with case fatalities ranging from 53% to 90%, while a third species, Côte d'Ivoire ebolavirus, caused a single non-fatal HF case. In November 2007, HF cases were reported in Bundibugyo District, Western Uganda. Laboratory investigation of the initial 29 suspect-case blood specimens by classic methods (antigen capture, IgM and IgG ELISA) and a recently developed random-primed pyrosequencing approach quickly identified this to be an Ebola HF outbreak associated with a newly discovered ebolavirus species (Bundibugyo ebolavirus) distantly related to the Côte d'Ivoire ebolavirus found in western Africa. Due to the sequence divergence of this new virus relative to all previously recognized ebolaviruses, these findings have important implications for design of future diagnostic assays to monitor Ebola HF disease in humans and animals, and ongoing efforts to develop effective antivirals and vaccines.


Related Papers

No related papers found

Powered by citation graph analysis